Form S-8

As filed with the Securities and Exchange Commission on May 2, 2014

Registration No. 333-                

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

DexCom, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   33-0857544

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification Number)

6340 Sequence Drive

San Diego, California 92121

(Address, including zip code, of Registrant’s principal executive offices)

 

 

2005 Equity Incentive Plan

(Full Title of the Plans)

 

 

Terrance H. Gregg

Chief Executive Officer

c/o DexCom, Inc.

6340 Sequence Drive

San Diego, California 92121

(858) 200-0200

(Name, Address and Telephone Number of Agent For Service)

 

 

Copies to:

Robert A. Freedman, Esq.

Michael A. Brown, Esq.

Fenwick & West LLP

801 California Street

Mountain View, CA 94041

(650) 988-8500

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated Filer   x    Accelerated Filer   ¨
Non-accelerated Filer   ¨  (Do not check if a smaller reporting company)    Smaller reporting company   ¨

 

 

CALCULATION OF REGISTRATION FEE

 

 

Title of Each Class of

Securities to be Registered

  

Amount

to be

Registered(1)

  

Proposed

Maximum

Offering Price

Per Share

  

Proposed

Maximum
Aggregate

Offering Price

   Amount of
Registration Fee

Common Stock, $0.001 par value(2)

   2,175,140(3)   $33.01(4)   $71,801,371.40(4)   $9,248.02

 

 

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock that become issuable under the 2005 Equity Incentive Plan (the “EIP”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that increases the number of the Registrant’s outstanding shares of common stock.
(2) Each share of common stock includes one stockholder right as described under “Description of Capital Stock” in the Registrant’s registration statement on Form S-1, as amended (File No. 333-122454).
(3) Shares to be registered and available for grant under the EIP resulting from the automatic annual 3% increase in the number of authorized shares available for issuance under the EIP.
(4) Estimated pursuant to Rule 457(c) and (h) of the Securities Act, solely for purposes of calculating the registration fee, based on the average of the high and low sales price reported on The NASDAQ Global Select Market on April 28, 2014.

 

 

 

STATEMENT PURSUANT TO GENERAL INSTRUCTION E TO FORM S-8

REGISTRATION OF ADDITIONAL SECURITIES

This registration statement (the “Registration Statement”) hereby incorporates by reference the contents of DexCom’s earlier registration statements on Form S-8 (registration numbers 333-188305 and 333-180421) filed with the Commission on May 2, 2013 and March 28, 2012, respectively.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 8. Exhibits.

The following exhibits are filed herewith:

 

              

Incorporated by Reference

          

Exhibit
Number

   

Exhibit Document

   

Form

   

File No.

   

Date of
First Filing

   

Exhibit
Number

   

Provided
Herewith

  4.01    Registrant’s Restated Certificate of Incorporation.    S-1/A    333-122454    March 3, 2005    3.03   
  4.02    Registrant’s Amended and Restated Bylaws.    8-K    000-51222    March 23, 2011    99.01   
  4.03    Form of Specimen Certificate for Registrant’s common stock.    S-1/A    333-122454    March 24, 2005    4.01   
  4.04    Form of Rights Agreement, between DexCom, Inc. and American Stock Transfer & Trust Company, including the Certificate of Designations of Series A Junior Participating Preferred Stock, Summary of Stock Purchase Rights and Forms of Right Certificate attached thereto as Exhibit A, B and C, respectively.    S-1/A    000-51222    March 24, 2005    4.03   
  4.05    2005 Equity Incentive Plan, as amended, and forms of stock option agreement and stock option exercise agreements.    10-Q    000-51222    May 3, 2011    10.25   
  4.06    Form of Restricted Stock Unit Award Agreement.    10-Q    000-51222    May 5, 2010    10.26   
  5.01    Opinion of Fenwick & West LLP regarding legality of the securities being registered.                X
23.01
   

Consent of Independent Registered Public Accounting Firm.

                X
23.02   

Consent of Fenwick & West LLP (included in Exhibit 5.01).

                X
24.01    Power of Attorney (see page II-5 of this registration statement).                X

SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on this 2nd day of May, 2014.

 

DEXCOM, INC.
By:  

/S/    TERRANCE H. GREGG        

 

Terrance H. Gregg

Chief Executive Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS that each individual whose signature appears below constitutes and appoints Terrance H. Gregg and Jess Roper, and each of them, his or her true and lawful attorneys-in-fact and agents with full power of substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done with respect to this Registration Statement, including post-effective amendments, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his substitute or substitutes, may lawfully do or cause to be done or by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

 

Name

   

Title

  

Date

Principal Executive Officer and Director:     

/S/    TERRANCE H. GREGG        

   

Chief Executive Officer and Director

(Principal Executive Officer)

   May 2, 2014
Terrance H. Gregg     
Principal Financial Officer and Principal Accounting Officer:     

/S/    JESS ROPER        

   

Chief Financial Officer

(Principal Financial and Accounting Officer)

   May 2, 2014
Jess Roper     
Additional Directors:     

/S/    JONATHAN LORD, M.D.        

   

Chairman of the Board of Directors

   May 2, 2014
Jonathan Lord, M.D.     

/S/    KEVIN SAYER        

   

President, Chief Operating Officer and Director

   May 2, 2014
Kevin Sayer     

/S/    JAY SKYLER, M.D.        

   

Director

   May 2, 2014
Jay Skyler, M.D.     

/S/    ERIC TOPOL, M.D.        

   

Director

   May 2, 2014
Eric Topol, M.D.     

/S/    NICHOLAS AUGUSTINOS        

   

Director

   May 2, 2014
Nicholas Augustinos     

/s/    STEVE ALTMAN        

   

Director

   May 2, 2014
Steve Altman     

/s/    BARBARA KAHN        

   

Director

   May 2, 2014
Barbara Kahn     

Exhibit Index

 

              

Incorporated by Reference

          

Exhibit
Number

   

Exhibit Document

   

Form

   

File No.

   

Date of

First Filing

   

Exhibit
Number

   

Provided
Herewith

  4.01    Registrant’s Restated Certificate of Incorporation.    S-1/A    333-122454    March 3, 2005    3.03   
  4.02    Registrant’s Amended and Restated Bylaws.    8-K    000-51222    March 23, 2011    99.01   
  4.03    Form of Specimen Certificate for Registrant’s common stock.    S-1/A    333-122454    March 24, 2005    4.01   
  4.04    Form of Rights Agreement, between DexCom, Inc. and American Stock Transfer & Trust Company, including the Certificate of Designations of Series A Junior Participating Preferred Stock, Summary of Stock Purchase Rights and Forms of Right Certificate attached thereto as Exhibit A, B and C, respectively.    S-1/A    000-51222    March 24, 2005    4.03   
  4.05    2005 Equity Incentive Plan, as amended, and forms of stock option agreement and stock option exercise agreements.    10-Q    000-51222    May 3, 2011    10.25   
  4.06    Form of Restricted Stock Unit Award Agreement.    10-Q    000-51222    May 5, 2010    10.26   
  5.01    Opinion of Fenwick & West LLP regarding legality of the securities being registered.                X
23.01
   

Consent of Independent Registered Public Accounting Firm.

                X
23.02
   

Consent of Fenwick & West LLP (included in Exhibit 5.01).

                X
24.01    Power of Attorney (see page II-5 of this registration statement).                X